| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |